|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Turning Point Therapeutics, Inc. (TPTX) |
|
|
$76.01 0.00 (0.00%) as of 4:30 Tue 8/16
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
48,170,000 |
| Market
Cap: |
3.66(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$76.01 - $76.01 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 116 |
| Guru Rank Value : 7.9 |
| Guru Occurances : 1 |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
1,183 |
| Total Sell Value |
$0 |
$0 |
$0 |
$88,654 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Alles Mark J |
Director |
– • – |
2021-06-21 |
4 |
B |
$81.34 |
$162,680 |
D/D |
2,000 |
2,000 |
2.39 |
-49% |
|
| North Annette |
EVP, General Counsel & Secty. |
• – – |
2021-05-06 |
4 |
OE |
$17.00 |
$99,994 |
D/D |
5,882 |
12,365 |
|
- |
|
| Baker Brian Lee |
SVP of Finance and Admin. |
• – – |
2021-03-23 |
4 |
AS |
$97.89 |
$2,862,082 |
D/D |
(28,435) |
4,116 |
|
-34% |
|
| Baker Brian Lee |
SVP of Finance and Admin. |
• – – |
2021-03-23 |
4 |
OE |
$2.19 |
$132,906 |
D/D |
28,435 |
32,551 |
|
- |
|
| Baker Brian Lee |
SVP of Finance and Admin. |
• – – |
2021-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,625 |
4,116 |
|
- |
|
| North Annette |
EVP, General Counsel & Secty. |
• – – |
2021-03-08 |
4 |
AS |
$103.30 |
$2,195,939 |
D/D |
(20,000) |
6,483 |
|
-37% |
|
| North Annette |
EVP, General Counsel & Secty. |
• – – |
2021-03-08 |
4 |
OE |
$17.00 |
$340,000 |
D/D |
20,000 |
26,483 |
|
- |
|
| Reich Siegfried |
EVP & Chief Scientific Officer |
• – – |
2021-03-04 |
4 |
AS |
$102.01 |
$3,734,075 |
D/D |
(35,550) |
3,845 |
|
-32% |
|
| Reich Siegfried |
EVP & Chief Scientific Officer |
• – – |
2021-03-04 |
4 |
OE |
$51.28 |
$1,823,004 |
D/D |
35,550 |
39,395 |
|
- |
|
| Countouriotis Athena |
President & CEO |
• • – |
2021-02-11 |
4 |
AS |
$136.45 |
$1,228,446 |
D/D |
(8,942) |
50,195 |
|
-41% |
|
| Countouriotis Athena |
President & CEO |
• • – |
2021-02-11 |
4 |
OE |
$3.20 |
$28,614 |
D/D |
8,942 |
59,137 |
|
- |
|
| Countouriotis Athena |
President & CEO |
• • – |
2021-02-10 |
4 |
AS |
$134.34 |
$3,461,116 |
D/D |
(25,392) |
50,195 |
|
-41% |
|
| Countouriotis Athena |
President & CEO |
• • – |
2021-02-10 |
4 |
OE |
$3.20 |
$81,254 |
D/D |
25,392 |
75,587 |
|
- |
|
| Countouriotis Athena |
President & CEO |
• • – |
2021-02-09 |
4 |
AS |
$136.29 |
$3,559,475 |
D/D |
(25,666) |
50,195 |
|
-41% |
|
| Countouriotis Athena |
President & CEO |
• • – |
2021-02-09 |
4 |
OE |
$3.20 |
$82,131 |
D/D |
25,666 |
75,861 |
|
- |
|
| Larson Yi |
EVP & Chief Financial Officer |
• – – |
2021-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,617 |
7,321 |
|
- |
|
| Countouriotis Athena |
President & CEO |
• • – |
2021-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
22,617 |
50,195 |
|
- |
|
| Baker Brian Lee |
SVP of Finance and Admin. |
• – – |
2021-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,483 |
2,491 |
|
- |
|
| Hirmand Mohammad |
EVP and Chief Medical Officer |
• – – |
2021-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,483 |
6,767 |
|
- |
|
| Reich Siegfried |
EVP & Chief Scientific Officer |
• – – |
2021-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,845 |
3,845 |
|
- |
|
| North Annette |
EVP, General Counsel & Secty. |
• – – |
2021-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,483 |
6,483 |
|
- |
|
| Partridge Andrew John |
EVP & Chief Commercial Officer |
• – – |
2021-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,136 |
23,636 |
|
- |
|
| Larson Yi |
EVP & Chief Financial Officer |
• – – |
2021-02-02 |
4 |
AS |
$127.58 |
$1,860,813 |
D/D |
(14,298) |
2,704 |
|
-41% |
|
| Larson Yi |
EVP & Chief Financial Officer |
• – – |
2021-02-02 |
4 |
OE |
$54.03 |
$772,521 |
D/D |
14,298 |
17,002 |
|
- |
|
| North Annette |
EVP, General Counsel & Secty. |
• – – |
2021-02-02 |
4 |
AS |
$126.66 |
$1,170,989 |
D/D |
(9,016) |
0 |
|
-41% |
|
142 Records found
|
|
Page 2 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
